Evidence map›Paper›PMID 41551073›Full record

ReviewInfectious diseases & clinical microbiology2025

Burden of Pneumococcal Disease and Adult Vaccination Landscape: An Overview with Data and Policy Insights from Türkiye.

Mine Durusu Tanrıöver, Mine Adaş, Hülya Çiçekçioğlu, Hasan Selçuk Özger, Güzin Zeren Öztürk, Meliha Çağla Sönmezer, Burçin Yazıcı, Onur Saydam, Orhan Aydoğdu, Abdullah Sayıner

Abstract readReview
In one paragraph

Review in Infectious diseases & clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mine Durusu TanrıöverHacettepe University Vaccine Institute, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-9565-4389
Mine AdaşDepartment of Endocrinology and Metabolism Disease, University of Health Sciences, Prof. Dr. Cemil Tascıoglu City Hospital, , İstanbul, Türkiye.ORCID https://orcid.org/0000-0003-3008-6581
Hülya ÇiçekçioğluCardiology Department, Ankara Bilkent City Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-6138-3699
Hasan Selçuk ÖzgerKoç University Hospitals, KUISCID, İstanbul, Türkiye.ORCID https://orcid.org/0000-0003-3894-0092
Güzin Zeren ÖztürkDepartment of Family Medicine, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, İstanbul, Türkiye.ORCID https://orcid.org/0000-0001-7730-2929
Meliha Çağla SönmezerDepartment of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-6529-5282
Burçin YazıcıPfizer Biopharmaceuticals, Primary Care-Vaccine, İstanbul, Türkiye.ORCID https://orcid.org/0009-0006-7883-1420
Onur SaydamPfizer Biopharmaceuticals, Primary Care-Vaccine, İstanbul, Türkiye.ORCID https://orcid.org/0000-0002-8968-6672
Orhan AydoğduPfizer Biopharmaceuticals, Primary Care-Vaccine, İstanbul, Türkiye.ORCID https://orcid.org/0009-0007-5514-3833
Abdullah SayınerDepartment of Chest Diseases, İzmir University of Economics School of Medicine, İzmir, Türkiye.ORCID https://orcid.org/0000-0002-6788-9727

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adultpneumococcalvaccine

Identifiers

PMID41551073
PMCPMC12805484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.